Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

TSXV:APC.H - Post Discussion

View:
Post by Willyzzz on Apr 28, 2022 3:02pm

Told you so, didn't I

This company has never delivered. All hype and no substance. Suspect leadership at the top and it trickles down to shareholder value. I can see this plummeting to under 10 cents by mid may.
Comment by Goldnboy1 on May 01, 2022 4:47pm
The company just reposted their investor deck. In it is a planned event calendar.  Im told there was a delay in development to ensure a conjugation patent had the best protection.  That's now complete.  Due to this the company can now file for new linker IP. The planned events calendar is showing the completion of a linker project in May it appears.  Typically ...more  
Comment by Willyzzz on May 03, 2022 1:19pm
$0.14 today. I was off by 3 days but nevertheless my prediction came true. How much lower will it go is now the million dollar question
Comment by FIRE2032 on May 07, 2022 7:45pm
i think its different this time around and they will deliver.... especially with who they have hired. if they can secure a licensing deal and get in to clinicals this will turn around quickly.    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities